Home / Treatments / Colonoscopy Sigmoid

Colonoscopy Sigmoid denials: what the review data shows

Independent reviewers have decided 102 published cases where an insurer denied Colonoscopy Sigmoid — and they overturned the insurer 39.2% of the time. A denial for Colonoscopy Sigmoid is a starting position, not a final answer.

Published decisions
102
2001–2026
Overturned
39.2%
40 denials reversed

Conditions behind colonoscopy sigmoid denials

What insurers denied — and how those fights ended.
CategoryDecisionsOverturned
Colon7
14.3%
Rectal Bleeding5
60%
Anemia3
100%
Abdominal Stomach Pain3
66.7%
GI Bleeding3
33.3%
Irritable Bowel3
0%

What the insurer actually argued

Denials fall into different categories, and they don’t succeed equally — so the reason on your letter changes how you should answer it.
Reason givenDecisionsOverturned
Medical Necessity
The plan said the care wasn’t medically necessary. The most common fight, and the most winnable.
90
37.8%
Experimental/Investigational
The plan called the treatment unproven. These turn on published evidence, so the appeal is a literature argument.
10
50%
Typical time to a decision
19 days
Most land between 11 and 21 days
Handled as urgent
7.8%
Expedited when a delay would cause harm
Recent direction
Rising
50%60% overturned, last three years
What the reviewers wrote
Excerpts from the independent reviewers’ published findings — the actual reasoning, quoted, not summarised.

Where the denial was overturned

Nature of Statutory Criteria/Case Summary: The patient requested authorization and coverage for a colonoscopy and monitored anesthesia care. The submitted documentation supports the medical necessity of the requested colonoscopy for evaluation of this patient. A review of the record reflects that the patient has been diagnosed with ulcerative colitis. Clinical guidelines from the American College of Gastroenterology (ACG) indicate that colonoscopy for dysplasia screening is recommended every one to three years in patients that have been diagnosed with ulcerative colitis for over eight years. Other studies have reported longstanding recommendations for a colonoscopy every one to two years in those patients. In this case, the patient has a history of active ulcerative colitis. Further, a review of the record establishes that the patient has not undergone a colonoscopy for a few years.
Medical Necessity · 2023 · IMR MN23-38996
Nature of Statutory Criteria/Case Summary: An enrollee has requested reimbursement for monitored anesthesia care for management of the enrollee’s pain during her colonoscopy. Findings: The physician reviewer found that according to the American Society of Anesthesiologists (ASA), an essential component of MAC anesthesia is the “anesthesia assessment and management of a patient’s actual or anticipated physiological derangements or medical problems that may occur during a diagnostic or therapeutic procedure.” Also, “While Monitored Anesthesia Care may include the administration of sedatives and/or analgesics often used for Moderate Sedation, the provider of MAC must be prepared and qualified to convert to general anesthesia when necessary.
Medical Necessity · 2017 · IMR MN17-25566

Where the denial was upheld

Worth reading too — these show what an appeal has to overcome.
The patient is a 56-year-old male who has requested authorization for a virtual colonoscopy for colon cancer screening. The patient has been on Coumadin for recurrent atrial fibrillation and he is concerned that discontinuing his anticoagulation therapy prior to a standard colonoscopy will put him at risk. Therefore, he is seeking approval of a virtual colonoscopy. The Health Plan has denied his request on the basis that a virtual colonoscopy is not medically necessary.Virtual colonoscopy represents a noninvasive test for the examination of the colonic lumen that involves the generation of both two-dimensional and three-dimensional views of the colon and rectum using data derived from computed tomography. This imaging modality has been explored as an alternative to conventional endoscopic colonoscopy, particularly as an alternative screening tool for colorectal cancer.
Medical Necessity · 2006 · IMR MN06-5783
The patient is a 55-year-old male who was referred by his provider for a screening colonoscopy in February 2005. The patient has no prior history of a screening colonoscopy and no prior history of a failed attempt or unsuccessful colonoscopy. The patient underwent a CT colonography (virtual colonoscopy) instead of a conventional optical colonoscopy, which revealed a normal appearing colon and two left renal calculi. At issue is whether the virtual colonoscopy was medically necessary for evaluation of the patient’s medical condition.Virtual colonoscopy represents a noninvasive test for the examination of the colonic lumen that involves the generation of both two-dimensional and three-dimensional views of the colon and rectum using data derived from computed tomography.
Medical Necessity · 2006 · IMR MN06-5712

Figures and quotations on this page come from 42,749 published decisions in the California DMHC Independent Medical Review dataset. These are California outcomes — every state runs an equivalent external review, but the rates here are California’s. Excerpts are quoted verbatim from the public record and describe this treatment generally, not any individual case.

How to use this in your appeal

These are outcomes from California’s external review program — an independent physician panel that binds the insurer. Every state has an equivalent process, and internal appeals succeed even more often. Cite the outcome record for Colonoscopy Sigmoidwhen you appeal: reviewers routinely find that denials like yours didn’t hold up.

SOURCE: CALIFORNIA DMHC INDEPENDENT MEDICAL REVIEW OUTCOMES (CHHS OPEN DATA) · DERIVED AGGREGATE STATISTICS ONLY · METHODOLOGY

Not legal or medical advice. Coverage Rights is a self-help tool that helps you prepare your own appeal. For advice about your specific situation, talk to a licensed attorney or your doctor.

Denied Colonoscopy Sigmoid? 39.2% got it reversed.

Explain my denial — freeStart my appeal · $39